Combination therapy of KRAS G12V mRNA vaccine and pembrolizumab: clinical benefit in patients with advanced solid tumors.
Wang X, Wang W, Zou S, Xu Z, Cao D, Zhang S, Wei M, Zhan Q, Wen C, Li F, Chen H, Fu D, Jiang L, Zhao M, Shen B.
Wang X, et al. Among authors: zou s.
Cell Res. 2024 Jun 24. doi: 10.1038/s41422-024-00990-9. Online ahead of print.
Cell Res. 2024.
PMID: 38914844
No abstract available.